Methylation of p16 CpG Island And Malignant Transformation of Oral Epithelial Dysplasia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00835341|
Recruitment Status : Completed
First Posted : February 3, 2009
Results First Posted : February 23, 2010
Last Update Posted : June 1, 2015
|Condition or disease|
|Oral Epithelial Dysplasia, Mild or Moderate Grade|
- Background: Identification of malignant potential of oral epithelial dysplasia (OED) is virtually impossible on histopathological grounds alone. Inactivation of p16 gene by CpG methylation is an early frequent event during oral carcinogenesis. To investigate the predictive value of p16 methylation on malignant potential in OED, we carried out the prospective cohort study.
- Methods: 101 patients with histologically confirmed mild or moderate OED were included in the present study. Baseline information of p16 methylation status of the OED lesions from 93 cases was obtained by methylation-specific PCR. Progression of the OEDs lesions was examined in 78 cases histologically during the 45.8 months double-blind followup survey (78/93). The association between p16 methylation and progression of OED was analyzed with SPSS13.0 software. All P-values were two-sided.
|Study Type :||Observational|
|Actual Enrollment :||93 participants|
|Official Title:||A Cohort Study on Prediction of Malignant Transformation of Oral Epithelial Dysplasia by p16 Methylation|
|Study Start Date :||March 2005|
|Actual Primary Completion Date :||October 2008|
|Actual Study Completion Date :||October 2008|
patients with mild or moderate oral epithelial dysplasia containing methylated p16 CpG island.
patients with mild or moderate oral epithelial dysplasia NOT containing methylated p16 CpG island.
- The Number of Participants With Both Clinical and Histological Evidence of Malignant Transformation of Oral Epithelial Dysplasia [ Time Frame: from 3 months to 124 months ]The follow-up examination was carried out with a 3-month interval. Re-biopsy was done as clinically indicated, e.g. the lesion recurs or has tendency for malignant development. Pathologic diagnosis was made by at least two pathologists without the knowledge of baseline p16 methylation, based on the World Health Organization's criteria, at Peking University School of Stomatology. The number of participants with malignant transformation of oral dysplasia was calculated based on the number of participants with oral dysplasia progressed to carcinoma by the end of the trial in each cohorts.
- Cancer-free Survival Time for Patients With Oral Epithelial Dysplasia [ Time Frame: from 3 months to 124 months ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00835341
|Department of Oral Medicine, Peking University School and Hospital of Stomatology|
|Beijing, China, 100081|
|Study Director:||Dajun Deng, MD||Beijing Cancer Hospital/ Institue, Peking University School of Oncology|
|Principal Investigator:||Hongwei Liu, MD, PhD||Peking University School of Stomatology|